Celldex Therapeutics Inc (CLDX), Seattle Genetics, Inc. (SGEN), Steven Madden, Ltd. (SHOO), Sun Life Financial Inc. (SLF), Crown Castle (CCI) and Celanese Co. (CE) ratings and price targets.
Jefferies (NYSE:JEF) reiterated its “Buy” rating on Seattle Genetics, Inc. (SGEN). They have a price target of $28.00 on the company.
Canaccord Genuity initiated coverage on Steven Madden, Ltd. (SHOO). They placed a “Buy” rating and a price target of $47.00 on the company.
Morgan Stanley (NYSE:MS) initiated coverage on Sun Life Financial Inc. (SLF). They placed an “Equal Weight” rating on the company.
Macquarie initiated coverage on Crown Castle (CCI). They placed an “Outperform” rating on the company.
Gilford Securities reiterated its “Hold” rating on Celanese Co. (CE).
Jefferies initiated coverage on Celldex Therapeutics Inc (CLDX). They placed a “Buy” rating and a price target of $4.00 on the company.
Friday, December 2, 2011
Celldex (CLDX) (SGEN) (SHOO) (SLF) (CCI) (CE) Ratings, Price Targets
Labels:
Seattle Genetics
Subscribe to:
Post Comments (Atom)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
No comments:
Post a Comment